David Ortlieb

Mr. Ortlieb brings 30+ years of experience in leading pharmaceutical commercialization as well as new target identification and commercial development planning. He has worked with a range of small molecules, biologics, and vaccines across many therapeutic areas. Mr. Ortlieb received his MBA from Northwestern University’s Kellogg Graduate School of Management and degrees in Biology and Chemistry from Indiana University.